Latest Research Parkinson Disease

latest research parkinson disease

Researchers at the University of Utah Health have identified a molecule that slows down the production of the toxic protein alpha-synuclein. The discovery could eventually lead to new ways of treating Parkinson disease and slowing its progression. This breakthrough was made by a team of scientists led by Associate Professor of Neurology Daniel Scoles. They reported their findings in the Journal of Biological Chemistry.

Parkinson’s disease is a group of neurological diseases that causes slow and abnormal movement. Some people are affected by both sporadic and hereditary forms of the disease. The symptoms can be similar to those of other diseases, but it’s important to know the differences between them. If you suspect you have Parkinson’s, you can get diagnosed and begin managing your condition.

Researchers are working to develop treatments for Parkinson’s disease based on stem-cell therapy. This therapy is a revolutionary new approach to treating neurodegenerative diseases. This treatment is currently being tested in a trial involving a select population of people with Parkinson’s disease. The study is being conducted at the Barrow Neurological Institute in Phoenix. The researchers are supported by a grant from the Michael J. Fox Foundation.

Parkinson’s disease is caused by the death of neurons in the brain. The disease causes symptoms like tremors, stiffness and slowed movements. It can also lead to dementia in its late stages. While there are treatments available to control symptoms, there is no way to stop the disease’s progression.

Share this article: